(Q46627659)

23 December 2017

title

Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis (English)

1 reference

23 December 2017

0 references

C Ohlsson

4

0 references

Marie K Lagerquist

2

object named as

M Lagerquist

1 reference

23 December 2017

author name string

C Jochems

1

1 reference

23 December 2017

C Håkansson

3

1 reference

23 December 2017

H Carlsten

5

1 reference

23 December 2017

publication date

24 April 2008

1 reference

23 December 2017

Clinical and Experimental Immunology

published in

1 reference

23 December 2017

volume

152

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

593-597

1 reference

23 December 2017

Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2453214

Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2453214

Genistein as an anti-inflammatory agent

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2453214

Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2453214

Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2453214

Bone resorption and inflammatory inhibition efficacy of intermittent cyclical etidronate therapy in rheumatoid arthritis

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2453214

Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2453214

Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2453214

Alendronate in rheumatoid arthritis patients treated with methotrexate and glucocorticoids

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2453214

Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2453214

Oestrogen induced suppression of collagen arthritis. IV: Progesterone alone does not affect the course of arthritis but enhances the oestrogen-mediated therapeutic effect

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2453214

Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2453214

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2453214

Homologous type II collagen induces chronic and progressive arthritis in mice

3 November 2018

1 reference

12 December 2020

Female sex hormones suppress development of collagen-induced arthritis in mice

1 reference

12 December 2020

Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients

1 reference

12 December 2020

Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy

1 reference

12 December 2020

A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis

1 reference

12 December 2020

Effects of ovariectomy and estrogen replacement therapy on arthritis and bone mineral density in rats with collagen-induced arthritis

1 reference

12 December 2020

Functional discrimination between interleukin 6 and interleukin 1

1 reference

12 December 2020

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

12 December 2020

Raloxifene therapy interacts with serum osteoprotegerin in postmenopausal women

1 reference

12 December 2020

Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

10.1111/J.1365-2249.2008.03660.X

Identifiers

DOI

1 reference

23 December 2017

0 references

1 reference

23 December 2017